JP2018148915A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018148915A5 JP2018148915A5 JP2018099529A JP2018099529A JP2018148915A5 JP 2018148915 A5 JP2018148915 A5 JP 2018148915A5 JP 2018099529 A JP2018099529 A JP 2018099529A JP 2018099529 A JP2018099529 A JP 2018099529A JP 2018148915 A5 JP2018148915 A5 JP 2018148915A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- group
- amino acid
- acid sequence
- sequence selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 15
- 101000830411 Homo sapiens Probable ATP-dependent RNA helicase DDX4 Proteins 0.000 claims description 6
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims description 5
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims description 5
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims description 5
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims description 5
- 102000055979 human DDX4 Human genes 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 1
- 102100024770 Probable ATP-dependent RNA helicase DDX4 Human genes 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462051130P | 2014-09-16 | 2014-09-16 | |
| US62/051,130 | 2014-09-16 | ||
| US201462089054P | 2014-12-08 | 2014-12-08 | |
| US62/089,054 | 2014-12-08 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511337A Division JP2017532953A (ja) | 2014-09-16 | 2015-09-16 | 抗ｖａｓａ抗体、ならびにその産生法および使用法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018148915A JP2018148915A (ja) | 2018-09-27 |
| JP2018148915A5 true JP2018148915A5 (enExample) | 2018-11-08 |
Family
ID=55454121
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511337A Pending JP2017532953A (ja) | 2014-09-16 | 2015-09-16 | 抗ｖａｓａ抗体、ならびにその産生法および使用法 |
| JP2018099529A Pending JP2018148915A (ja) | 2014-09-16 | 2018-05-24 | 抗ｖａｓａ抗体、ならびにその産生法および使用法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017511337A Pending JP2017532953A (ja) | 2014-09-16 | 2015-09-16 | 抗ｖａｓａ抗体、ならびにその産生法および使用法 |
Country Status (26)
| Country | Link |
|---|---|
| US (4) | US9403913B2 (enExample) |
| EP (1) | EP3194448A4 (enExample) |
| JP (2) | JP2017532953A (enExample) |
| KR (1) | KR20170056521A (enExample) |
| CN (1) | CN106573985A (enExample) |
| AP (1) | AP2017009758A0 (enExample) |
| AU (1) | AU2015317813B2 (enExample) |
| BR (1) | BR112017003263A2 (enExample) |
| CA (1) | CA2959179A1 (enExample) |
| CL (1) | CL2017000402A1 (enExample) |
| CO (1) | CO2017001724A2 (enExample) |
| CR (1) | CR20170067A (enExample) |
| DO (1) | DOP2017000050A (enExample) |
| EA (1) | EA201790236A1 (enExample) |
| EC (1) | ECSP17011262A (enExample) |
| GT (1) | GT201700036A (enExample) |
| IL (1) | IL250451A0 (enExample) |
| MX (1) | MX358243B (enExample) |
| NI (1) | NI201700022A (enExample) |
| PE (1) | PE20170667A1 (enExample) |
| PH (1) | PH12017500309A1 (enExample) |
| SG (1) | SG11201701016WA (enExample) |
| SV (1) | SV2017005393A (enExample) |
| TN (1) | TN2017000066A1 (enExample) |
| TW (1) | TW201619194A (enExample) |
| WO (1) | WO2016044436A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3252079B8 (en) | 2006-04-07 | 2020-09-09 | Aerpio Therapeutics LLC | Antibodies that bind human protein tyrosine phosphatase beta (hptp-beta) and uses thereof |
| AU2012323856B2 (en) | 2011-10-13 | 2017-05-25 | EyePoint Pharmaceuticals, Inc. | Methods for treating Vascular Leak Syndrome and cancer |
| CA2959179A1 (en) * | 2014-09-16 | 2016-03-24 | Ovascience, Inc. | Anti-vasa antibodies, and methods of production and use thereof |
| WO2018017714A1 (en) | 2016-07-20 | 2018-01-25 | Aerpio Therapeutics, Inc. | HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-ß) |
| US10894824B2 (en) | 2018-09-24 | 2021-01-19 | Aerpio Pharmaceuticals, Inc. | Multispecific antibodies that target HPTP-β (VE-PTP) and VEGF |
| WO2020102565A2 (en) | 2018-11-14 | 2020-05-22 | Flagship Pioneering Innovations V, Inc. | Systems and methods for nondestructive testing of gametes |
| WO2021096829A1 (en) * | 2019-11-11 | 2021-05-20 | Vanderbilt University | Human monoclonal antibodies to hantavirus and methods of use therefor |
| CN120405134A (zh) * | 2024-01-30 | 2025-08-01 | 抟相医药(杭州)有限公司 | 基于凝聚体荧光漂白恢复技术(Drop-FRAP)的生物大分子相互作用调节剂筛选平台 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996039518A1 (en) * | 1995-06-05 | 1996-12-12 | Bionebraska, Inc. | Lead binding polypeptides and nucleotides coding therefor |
| WO2001036445A1 (en) * | 1999-11-18 | 2001-05-25 | The Brigham And Women's Hospital, Inc. | Compositions and methods for the improved diagnosis and treatment of germ cell tumors |
| US6875854B1 (en) * | 1999-11-18 | 2005-04-05 | The Brigham And Women's Hospital, Inc. | Compositions and methods for the improved diagnosis and treatment of germ cell tumors |
| US7955846B2 (en) | 2004-05-17 | 2011-06-07 | The General Hospital Corporation | Compositions comprising female germline stem cells and methods of use thereof |
| CA2566857A1 (en) | 2004-05-17 | 2005-12-01 | The General Hospital Corporation | Methods and compositions for producing germ cells from peripheral blood derived germline stem cells |
| DE602005024502D1 (de) * | 2004-07-09 | 2010-12-16 | Chugai Pharmaceutical Co Ltd | Anti-glypican-3-antikörper |
| EP1829961A4 (en) * | 2004-12-22 | 2008-06-04 | Chugai Pharmaceutical Co Ltd | PROCESS FOR PREPARING ANTIBODY USING A CELL WHOSE FUCOSE CARRIER FUNCTION IS INHIBITED |
| US20110244485A1 (en) | 2008-09-25 | 2011-10-06 | National University Corporation Tokyo University Of Marine Science And Technology | Anti-tuna vasa antibody |
| AU2009331178A1 (en) * | 2008-12-26 | 2011-08-11 | Forerunner Pharma Research Co., Ltd. | Diagnosis and treatment of cancer using anti-LGR7 antibody |
| JP5769316B2 (ja) * | 2009-08-06 | 2015-08-26 | イムナス・ファーマ株式会社 | Ａβオリゴマーに特異的に結合する抗体およびその利用 |
| SG194448A1 (en) | 2011-04-14 | 2013-12-30 | Gen Hospital Corp | Compositions and methods for autologous germline mitochondrial energy transfer |
| UA117448C2 (uk) * | 2011-06-29 | 2018-08-10 | Зе Дженерел Хоспітел Корпорейшн | Середовище клітинної культури для культивування ооцита |
| US9428575B2 (en) * | 2012-12-31 | 2016-08-30 | Development Center For Biotechnology | Anti-granulysin antibodies and methods of use thereof |
| CA2959179A1 (en) * | 2014-09-16 | 2016-03-24 | Ovascience, Inc. | Anti-vasa antibodies, and methods of production and use thereof |
| EP3245287A4 (en) * | 2015-01-13 | 2018-06-20 | President and Fellows of Harvard College | Purification of germ stem cells by targeting mrp9 |
-
2015
- 2015-09-16 CA CA2959179A patent/CA2959179A1/en not_active Abandoned
- 2015-09-16 TN TN2017000066A patent/TN2017000066A1/en unknown
- 2015-09-16 EP EP15841982.0A patent/EP3194448A4/en not_active Withdrawn
- 2015-09-16 PE PE2017000250A patent/PE20170667A1/es not_active Application Discontinuation
- 2015-09-16 SG SG11201701016WA patent/SG11201701016WA/en unknown
- 2015-09-16 CN CN201580045293.8A patent/CN106573985A/zh active Pending
- 2015-09-16 JP JP2017511337A patent/JP2017532953A/ja active Pending
- 2015-09-16 WO PCT/US2015/050449 patent/WO2016044436A2/en not_active Ceased
- 2015-09-16 EA EA201790236A patent/EA201790236A1/ru unknown
- 2015-09-16 US US14/856,380 patent/US9403913B2/en not_active Expired - Fee Related
- 2015-09-16 TW TW104130554A patent/TW201619194A/zh unknown
- 2015-09-16 CR CR20170067A patent/CR20170067A/es unknown
- 2015-09-16 AP AP2017009758A patent/AP2017009758A0/en unknown
- 2015-09-16 AU AU2015317813A patent/AU2015317813B2/en not_active Ceased
- 2015-09-16 BR BR112017003263A patent/BR112017003263A2/pt not_active Application Discontinuation
- 2015-09-16 KR KR1020177005227A patent/KR20170056521A/ko not_active Withdrawn
- 2015-09-16 MX MX2017002390A patent/MX358243B/es active IP Right Grant
-
2016
- 2016-07-06 US US15/203,040 patent/US9567404B2/en not_active Expired - Fee Related
- 2016-12-30 US US15/395,114 patent/US20170107299A1/en not_active Abandoned
-
2017
- 2017-02-05 IL IL250451A patent/IL250451A0/en unknown
- 2017-02-17 CL CL2017000402A patent/CL2017000402A1/es unknown
- 2017-02-20 PH PH12017500309A patent/PH12017500309A1/en unknown
- 2017-02-21 EC ECIEPI201711262A patent/ECSP17011262A/es unknown
- 2017-02-23 SV SV2017005393A patent/SV2017005393A/es unknown
- 2017-02-23 GT GT201700036A patent/GT201700036A/es unknown
- 2017-02-23 CO CONC2017/0001724A patent/CO2017001724A2/es unknown
- 2017-02-23 DO DO2017000050A patent/DOP2017000050A/es unknown
- 2017-02-23 NI NI201700022A patent/NI201700022A/es unknown
- 2017-09-25 US US15/714,823 patent/US20180155445A1/en not_active Abandoned
-
2018
- 2018-05-24 JP JP2018099529A patent/JP2018148915A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018148915A5 (enExample) | ||
| CN112794899B (zh) | 一种抗新型冠状病毒的全人源单克隆中和抗体及其应用 | |
| JP2023510589A (ja) | ＨＢｃＡｇの検出方法及び抗体 | |
| WO2025015726A1 (zh) | 抗cd19抗体的抗体、抗cd22抗体的抗体及其应用 | |
| CN116813780B (zh) | 抗人cd31兔单克隆抗体及其应用 | |
| CN111303286B (zh) | 一种anti-CD19的全人源抗体或抗体片段及其嵌合抗原受体和应用 | |
| CN115819590B (zh) | 抗猪红细胞膜抗体的制备及应用 | |
| CN115838419A (zh) | 抗呼吸道合胞病毒抗体及其相关应用 | |
| CN115925909A (zh) | 抗呼吸道合胞病毒抗体及其相关应用 | |
| WO2022037002A1 (zh) | 特异性结合糖基化ceacam5的抗体 | |
| CN109942702B (zh) | 一种人鼠嵌合抗HEV全分子IgG及其应用 | |
| CN113683692B (zh) | SARS-CoV-2 N蛋白抗体及其应用 | |
| CN111892657B (zh) | 用于检测米田堡血型抗原的抗体及其片段、试剂盒及方法 | |
| CN116355094B (zh) | 抗小鼠白介素12的单克隆抗体及制备方法 | |
| CN119119254A (zh) | 一种特异性结合小反刍兽疫病毒磷蛋白的单克隆抗体 | |
| KR20230124280A (ko) | 메르스 코로나 바이러스의 뉴클레오캡시드 단백질에 특이적인 진단용 항체 및 이의 용도 | |
| CN115894692A (zh) | 一种靶向cd47的抗体及其应用 | |
| JPWO2022045126A5 (enExample) | ||
| CN111876476A (zh) | 用于扩增马抗体的巢式pcr引物、试剂盒及其应用 | |
| CN119638838B (zh) | 一种抗程序化死亡分子1的纳米抗体及其应用 | |
| CN113651883B (zh) | 人源化抗HAdV-B7单克隆中和抗体、制备方法及其应用 | |
| CN118307667A (zh) | 一种抗呼吸道合胞病毒的抗体及其用途 | |
| US10995134B2 (en) | Method for development of monoclonal antibodies | |
| CN118126166A (zh) | 一种SARS-CoV-2的抗体1A03及其用途 | |
| CN120399081A (zh) | 靶向gpc3的抗体及其应用 |